Open Access

[Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells

  • Authors:
    • Chunlan Tang
    • Hu Luo
    • Dan Luo
    • Heping Yang
    • Xiangdong Zhou
  • View Affiliations

  • Published online on: August 26, 2025     https://doi.org/10.3892/or.2025.8979
  • Article Number: 146
  • Copyright : © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the immunohistochemical images shown in Figs. 1E and 5E appeared to show an overlapping section, even though Figs. 1 and 5 were intended to show the results of SHP2 and Ras expression experiments, respectively. The authors were contacted by the Editorial Office to offer an explanation for this apparent anomaly in the presentation of the data in this paper; however, up to this time, no response from them has been forthcoming. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [Oncology Reports 39: 611‑618, 2018; DOI: 10.3892/or.2017.6109]

Related Articles

Journal Cover

November-2025
Volume 54 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tang C, Luo H, Luo D, Yang H and Zhou X: [Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. Oncol Rep 54: 146, 2025.
APA
Tang, C., Luo, H., Luo, D., Yang, H., & Zhou, X. (2025). [Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. Oncology Reports, 54, 146. https://doi.org/10.3892/or.2025.8979
MLA
Tang, C., Luo, H., Luo, D., Yang, H., Zhou, X."[Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells". Oncology Reports 54.5 (2025): 146.
Chicago
Tang, C., Luo, H., Luo, D., Yang, H., Zhou, X."[Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells". Oncology Reports 54, no. 5 (2025): 146. https://doi.org/10.3892/or.2025.8979